The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study
- PMID: 38946688
- PMCID: PMC11350139
- DOI: 10.1002/alz.14033
The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study
Abstract
Background: We assessed the relationship of liver fibrosis score with incident dementia in a large, national sample.
Methods: For this retrospective cohort study, data of dementia-free individuals aged 40-69 years were derived from electronic records of the largest healthcare provider in Israel. The association between liver fibrosis score (FIB-4), assessed from routine laboratory measurements, and incident dementia was explored through multivariate cox regression models.
Results: Of the total sample (N = 826,578, mean age 55 ± 8 years at baseline), 636,967 (77%) had no fibrosis, 180,114 (21.8%) had inconclusive fibrosis status and 9497 (1.2%) had high risk for advanced fibrosis. Over a median follow-up of 17 years, 41,089 dementia cases were recorded. Inconclusive liver fibrosis and advanced fibrosis were associated with increased dementia risk (HR = 1.09, 95%CI: 1.07-1.11 and HR = 1.18, 95%CI: 1.10-1.27, respectively). This association remained robust through seven sensitivity analyses.
Conclusions: Liver fibrosis assessed through a serum-based algorithm may serve as a risk factor for dementia in the general population.
Highlights: Liver fibrosis may predict dementia diagnosis in the general population. Inconclusive liver fibrosis was associated with 9% increased dementia risk. Advanced liver fibrosis was associated with 18% increased dementia risk. Findings remained robust in sensitivity analyses and after adjustments.
Keywords: cohort study; dementia; liver fibrosis; risk factors.
© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors declare no conflicts of interest. Author disclosures are available in the Supporting information.
Figures
Similar articles
-
Liver Fibrosis Marker FIB-4 Is Associated With Hepatic and Extrahepatic Malignancy Risk in a Population-Based Cohort Study.Liver Int. 2025 Jun;45(6):e70139. doi: 10.1111/liv.70139. Liver Int. 2025. PMID: 40358032
-
Association between liver fibrosis and incident dementia in the UK Biobank study.Eur J Neurol. 2022 Sep;29(9):2622-2630. doi: 10.1111/ene.15437. Epub 2022 Jun 20. Eur J Neurol. 2022. PMID: 35666174 Free PMC article.
-
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population.Dig Liver Dis. 2021 Jan;53(1):79-85. doi: 10.1016/j.dld.2020.10.014. Epub 2020 Nov 2. Dig Liver Dis. 2021. PMID: 33144054
-
Liver Fibrosis Assessed Via Noninvasive Tests Is Associated With Incident Heart Failure in a General Population Cohort.Clin Gastroenterol Hepatol. 2024 Aug;22(8):1657-1667. doi: 10.1016/j.cgh.2024.03.045. Epub 2024 May 8. Clin Gastroenterol Hepatol. 2024. PMID: 38723982
-
FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):184-191. doi: 10.1016/j.pcad.2020.02.010. Epub 2020 Feb 15. Prog Cardiovasc Dis. 2020. PMID: 32068085 Free PMC article. Review.
Cited by
-
Autophagy and Alzheimer's Disease: Mechanisms and Impact Beyond the Brain.Cells. 2025 Jun 16;14(12):911. doi: 10.3390/cells14120911. Cells. 2025. PMID: 40558538 Free PMC article. Review.
-
Bridging systemic metabolic dysfunction and Alzheimer's disease: the liver interface.Mol Neurodegener. 2025 May 28;20(1):61. doi: 10.1186/s13024-025-00849-6. Mol Neurodegener. 2025. PMID: 40437610 Free PMC article. Review.
-
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.Biomedicines. 2025 Apr 2;13(4):855. doi: 10.3390/biomedicines13040855. Biomedicines. 2025. PMID: 40299427 Free PMC article. Review.
-
Association between liver biomarkers and risk of cognitive impairment and dementia: A systematic review and meta-analysis.Pak J Med Sci. 2025 Jul;41(7):2122-2132. doi: 10.12669/pjms.41.7.12321. Pak J Med Sci. 2025. PMID: 40735554 Free PMC article. Review.
References
-
- Organization WH . Global action plan on the public health response to dementia 2017‐2025. 2017.
-
- Wong VW‐S, Ekstedt M, Wong GL‐H, et al. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79:842‐852. - PubMed
-
- Stefan N, Häring HU, Cusi K. Non‐alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7:313‐324. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical